Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL21817009

CC(C)CCCC(C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OC(=O)Cc5ccccc5)CC[C@]4(C)[C@H]3CC[C@]12C.N

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLA1 P09884 1/20 0.71
▸ CYP46A1 Q9Y6A2 2/20 0.67
▸ OSBP P22059 3/20 0.63
▸ USP2 O75604 2/20 0.63
▸ LMNA P02545 1/20 0.63
▸ ABCB1 P08183 1/20 0.63
▸ RORC P51449 1/20 0.63
▸ OSBP2 Q969R2 1/20 0.63
▸ NPC1 O15118 1/20 0.57
▸ CYP1A2 P05177 1/20 0.57
▸ NR1H3 Q13133 4/20 0.56
▸ PLA2G2A P14555 1/20 0.56
▸ NPC1L1 Q9UHC9 2/20 0.55
▸ EPHA2 P29317 1/20 0.55
▸ GBA1 P04062 2/20 0.55
▸ UGCG Q16739 2/20 0.55
▸ GBA2 Q9HCG7 2/20 0.55
▸ STS P08842 1/20 0.54
▸ GRIN1 Q05586 1/20 0.54
▸ GRIN2A Q12879 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10936315 0.99 POLA1 (0.72) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL23070074 0.99 POLA1 (0.72) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL2050990 0.99 POLA1 (0.72) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL2050989 0.99 POLA1 (0.72) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL7787257 0.92 POLA1 (0.70) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL29055425 0.92 POLA1 (0.70) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL5888346 0.92 POLA1 (0.68) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL7787254 0.92 POLA1 (0.70) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL21177708 0.92 POLA1 (0.70) POLA1CYP46A1OSBPUSP2LMNA
SCHEMBL5888344 0.92 POLA1 (0.68) POLA1CYP46A1OSBPUSP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119185572-A Ligand-drug conjugate of irinotecan analogue, preparation method and application thereof 江苏恒瑞医药股份有限公司 2024-12-27 — — CN disclosed
CN-118105513-A Conjugates comprising self-degrading groups and methods related thereto 乐高化学生物科学股份有限公司 2024-05-31 — — CN disclosed
WO-2020063676-A1 LIGAND-DRUG CONJUGATE OF EXATECAN ANALOGUE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江苏恒瑞医药股份有限公司 2020-04-02 — — WO disclosed
Send feedback